We describe the synthesis of a symmetrical N , N ′-bis(3-(1 H -imidazol-1-yl)propyl)oxalamide-based receptor OX(PID) 2 and its characterization by different physicochemical techniques, namely FT-IR, 1 H and 13 C NMR, TGA, and mass spectrometry.
No takes yet. Share an insight, caveat, or question.
Murugaperumal et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: